logo
Select company
Select metric
Ticker Information

Ticker

CELU

Company Name

CELULARITY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CELULARITY INC - Debt to Equity Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CELU - D/E Historical data
DateDebt to Equity RatioShareholders EquityTotal Liabilities
6/30/20250$ -25.5M$ 145.78M
12/31/202414.01$ 8.84M$ 123.84M
9/30/20246.46$ 17.28M$ 111.56M
6/30/20243.87$ 27.81M$ 107.68M
3/31/20243.6$ 31.25M$ 112.57M
12/31/20232.51$ 40.96M$ 102.93M
9/30/20234.2$ 30.25M$ 126.94M
6/30/20231.08$ 118.5M$ 127.92M
3/31/20231.33$ 155.63M$ 206.79M
12/31/20221.02$ 198.9M$ 202.16M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CELULARITY INC's latest trailing twelve months (TTM) D/E stands at 2.19.
  • Over the past 5 years, CELULARITY INC's average D/E has been 3.58.
  • The median D/E for CELULARITY INC during this period was 3.01
  • CELULARITY INC reached its highest D/E over the past 5 years at 14.01.
  • The lowest D/E recorded by CELULARITY INC in the same timeframe 1.02

CELULARITY INC's D/E vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

D/E Benchmarks
CompanyD/E
IVVD : INVIVYD INC 1.08SPRO : SPERO THERAPEUTICS INC 0.89CSBR : CHAMPIONS ONCOLOGY INC 7.7DOMH : DOMINARI HOLDINGS INC 0.24PLX : PROTALIX BIOTHERAPEUTICS INC 0.57MGX : METAGENOMI INC 0.39SEER : SEER INC 0.12WHWK : WHITEHAWK THERAPEUTICS INC 0.05THTX : THERATECHNOLOGIES INC -FBIO : FORTRESS BIOTECH INC 2.79

Definition of Debt to Equity Ratio

[Calculation] Debt to Equity (D/E) measures the ratio between a company’s [Liabilities] and [Equity]. A high ratio might indicate more risk.
Liabilities / Equity
(=) D/E
D/E for CELULARITY INC is calculated as follows: Liabilities [ $ 10.96M ] / Equity [ $ 5M ]
(=) D/E [ 2.19 ]

CELU - Debt to Equity Ratio, Last 5 years

1.02

Minimum

Dec 31, 2022

14.01

Maximum

Dec 31, 2024

3.58

Average

3.01

Median

D/E Benchmark Analysis

The chart above depicts the distribution of D/E for companies in the Total Stock Market. The average D/E of the companies is 1.39 with a standard deviation of 1.31.
The following table provides additional summary stats:
D/E in the Market:
filtered constituents3.3K
min0
max6.05
average1.39
median0.98
std1.31